IFPA2018

Session information

Poster Session

[P2] Poster Session 2

Sat. Sep 22, 2018 5:00 PM - 7:00 PM Room 7 (6F, Building No.1 (Poster③))

Hannah Ee Juen Yong1, Jorge Lopez-Tello1, Ionel Sandovici2,3, Miguel Constancia2,3, Amanda Sferruzzi-Perri1 (1. Centre for Trophoblast Research, University of Cambridge, Cambridge, United Kingdom, 2. Metabolic Research Laboratories, and MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom, 3. Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, United Kingdom)

Akihiro Hasegawa1, Michihiro Yamamura1, Keiko Yabuzaki1, Tomona Matsuoka1, Yuki Ito1, Haruhiko Udagawa1, Kazuhiro Kajiwara1, Taizan Kamide1, Hiroaki Aoki1, Seiji Wada2, Haruhiko Sago2, Osamu Samura1, Aikou Okamoto1 (1. Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan, 2. National Center of Child Development and Health, Tokyo, Japan)

Prabha Andraweera1, Claire Roberts1, Shalem Leemaqz1, Lesley McCowan2, Jenny Myers3, Louise Kenny4, James Walker5, Lucilla Poston6, Gus Dekker1,7 (1. Adelaide Medical School and The Robinson Research Institute, The University of Adelaide, Adelaide, Australia, 2. Department of Obstetrics and Gynaecology, The University of Auckland, Aucklan, New Zealand, 3. Maternal and Fetal Health Research Centre, University of Manchester, Manchester, United Kingdom, 4. The Irish Centre for Fetal and Neonatal Translational Research (INFANT) and Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland, 5. Department of Obstetrics and Gynaecology, Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom, 6. Division of Women’s Health, King’s College London and St Thomas’ Hospital, London, London, United Kingdom, 7. Division of Women’s Health, Lyell McEwin Hospital, Elizabeth Vale, Australia)

Åsa Edvinsson1, Jocelien Olivier2, Charlotte Hellgren1, Theodora Kunovac Kallak1, Helena Åkerud3, Alkistis Skalkidou1, Elisabeth Stener Victorin4, Romina Fornes5, Olav Spigset6,7, Susanne Lager1, Inger Sundström Poromaa1 (1. Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden, 2. Department of Neurobiology, unit Behavioral Neuroscience, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, Netherlands, 3. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 4. Department of Physiology and Pharmacology, Karolinska Institute,, Stockholm, Sweden, 5. Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden, 6. Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway, 7. Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway)

Natalia Anahí Juiz1, Irma Torrejón2, MIRIAM SALVO3, Ana María Fernanda Torres2, Tomás Duffy4, Nelly Melina Cayo2, Silvia Andrea Longhi1, Alejandro Gabriel Schijman1, ANAHI TABASCO1 (1. INGEBI-CONICET, CABA, Argentina, 2. Universidad Nacional de Jujuy, Jujuy, Argentina, 3. Hospital Nacional Profesor Alejandro Posadas, BUENOS AIRES, Argentina, 4. The Scripps Research Institute, La Joya, USA)

Agnieszka Jabłońska1, Mirosława Studzińska1, Jarosław Kalinka2, Edyta Paradowska1 (1. Laboratory of Molecular Virology and Biological Chemistry, Institute of Medical Biology of the Polish Academy of Sciences, Lodz, Poland, 2. Department of Perinatology, First Chair of Gynecology and Obstetrics, Medical University of Lodz, Lodz, Poland)

Chaini Konwar1,2, E Magda Price2,3, Giulia Del Gobbo1,2, Samantha Wilson1,2,4, Irina Manokhina1,2, Terry Jefferson1,5,
Wendy Robinson1,2
(1. BC Children’s Hospital Research Institute (BCCHR), Vancouver, Canada, 2. Department of Medical Genetics, University of British Columbia (UBC), Vancouver, Canada, 3. Department of Pediatrics, University of British Columbia (UBC), Vancouver, Canada, 4. Princess Margaret Cancer Centre, Department of Research, Toronto, Canada, 5. Department of Pathology, BC Children’s Hospital, Vancouver, Canada)

Jorge Lopez-Tello1, Hannah Ee Juen Yong1, Ionel Sandovici2,3, Miguel Constancia2,3, Amanda Sferruzzi-Perri1 (1. Centre for Trophoblast Research, University of Cambridge, Cambridge, United Kingdom, 2Metabolic Research Laboratories, and MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom, 3. Department of Obstetrics and Gynaecology, University of Cambridge., Cambridge, United Kingdom)

Padraig Looney1, Gordon Stevenson2, Kypros Nicolaides3, Walter Plasencia4, Malid Molloholli5,6, Stavros Natsis5, Sally Collins1,5 (1. Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, United Kingdom, 2. School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia, 3. Harris Birthright Research Centre of Fetal Medicine, King’s College Hospital, London, United Kingdom, 4. Fetal Medicine Unit, Hospiten Group, Tenerife, Spain, 5. Fetal Medicine Unit, John Radcliffe Hospital, Oxford, United Kingdom, 6. Department of Obstetrics and Gynaecology, Wexham Park Hospital, Slough, United Kingdom)